PAR Clinical and Innvocept Solutions Join Forces

 PAR Clinical and Innvocept Solutions Join Forces to offer Global Solutions

Exciting Strategic Collaboration Announcement 

Press Release: Boston, Massachusetts: 14 October 2024:

 We are thrilled to announce a strategic collaboration between PAR Clinical, USA and Innvocept Global Solutions LLC, USA and its affiliates two innovative forces in clinical drug development and technology solutions.

This collaboration marks a pivotal step toward expanding both companies' global capabilities. By combining PAR Clinical's expertise in clinical drug development with Innvocept’ s clinical trial management and technological prowess, we aim to provide cutting-edge, integrated solutions that streamlines drug development through scientific, regulatory, and operational expertise leading to efficient clinical trial process, accelerate timelines, and improve global healthcare outcomes.

Together, we are committed to offering innovative, efficient, and compliant solutions to meet the growing demands of the healthcare and life sciences sectors.

🌍 Global Reach
💡 Innovative Solutions
⚙️ Seamless Integration

About PAR Clinical:

PAR Clinical is an emerging strategic knowledge research organization with scientific, regulatory, and operational capabilities to partner in the drug discovery process, offering comprehensive solutions that accelerate the development of novel therapies. Specializing in advising early-stage drug development companies, PAR Clinical collaborates with pharmaceutical and biotech companies helping them transition from bench to bed improving the probability of success and de-risking assets as they mature with their clinical data and navigate various regulatory landscapes. With a strong focus on innovation, compliance, and efficiency, PAR Clinical is dedicated to advancing early-stage companies' vision of bringing breakthrough treatments that improve patient outcomes worldwide.

About Innvocept Global Solutions:

Innvocept Global Solutions is a leading provider of comprehensive services and technology solutions tailored for the healthcare and life sciences sectors. With a strong focus on Real World Evidence (RWE), clinical operations, and data-driven insights, Innvocept supports all phases of clinical research—from early discovery to post-market studies. Their end-to-end offerings are designed to ensure efficiency, compliance, and high-quality outcomes at every stage of drug development.

Innvocept’s expertise includes advanced medical writing, biometrics, clinical data management, and statistical analysis, all supported by a robust suite of clinical systems. This includes Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC) systems, Randomization and Trial Supply Management (RTSM), Electronic Patient-Reported Outcomes (ePRO), and Pharmacovigilance (PV) systems, ensuring streamlined processes, real-time monitoring, and regulatory compliance.

With a strong commitment to operational excellence, Innvocept’s global reach and integrated solutions help pharmaceutical, biotech, and medical device companies accelerate their clinical trials, optimize patient recruitment, and enhance data accuracy for faster regulatory submissions.

This collaboration will allow us to explore new opportunities and deliver added value to clients around the world.

Stay tuned for more exciting updates as we embark on this journey together!

#StrategicCollaboration #ClinicalTrials #HealthcareInnovation #GlobalCapabilities #PARClinical #InnvoceptSolutions

Manish Rajak, 

CEO and Co-founder, Innvocept Solutions

Our collaboration with PAR Clinical strengthens Innvocept Global Solutions' ability to deliver seamless, end-to-end clinical research services in US. With PAR Clinical’s expertise in clinical trials and Innvocept’s global operational capabilities, we are uniquely positioned to provide innovative, cost-effective solutions that accelerate time to market for life-saving therapies. This partnership reflects our shared commitment to quality, compliance, and the advancement of healthcare solutions worldwide.

We are pleased to announce that Siddharth will also be spearheading strategic business opportunities for Innvocept in the US and other international markets as a strategic business consultant. His expertise will be invaluable as we continue to expand our global reach, ensuring that Innvocept’s services are accessible wherever our clients require support. Siddharth’s leadership will further strengthen our commitment to providing comprehensive and customized solutions worldwide.”

Sid Parulkar,  

CEO and Founder, PAR Clinical 

We are excited to announce our collaboration with Innvocept Solutions.  Our relationship with Innvocept Solutions has evolved and having worked with them over the years we see great value that we can bring to our clients with this collaboration. At PAR Clinical we are focused on growing organically, ensuring that we are adequately resourced to support our client needs. As we are evolving in our journey it is imperative for us to collaborate with the right partners to expand our offerings to our clients. We have the foundational elements to support early-stage drug development companies and with this collaboration we will be expanding our reach globally utilizing Innvocept Solution’s operational strengths and their innovative technology platforms to continue providing value to our clients. 

We look forward to building this relationship further.     

For media inquiries, please contact:

Sid Parulkar, CEO PAR Clinical LLC 

Email: [email protected]. 

Phone +1 (919) 607-9071